These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 8589298

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of 3 vancomycin dosage regimens during hemodialysis with cellulose triacetate dialyzers: post-dialysis versus intradialytic administration.
    Mason NA, Neudeck BL, Welage LS, Patel JA, Swartz RD.
    Clin Nephrol; 2003 Aug; 60(2):96-104. PubMed ID: 12940611
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Vancomycin elimination during high-flux hemodialysis: kinetic model and comparison of four membranes.
    DeSoi CA, Sahm DF, Umans JG.
    Am J Kidney Dis; 1992 Oct; 20(4):354-60. PubMed ID: 1415203
    [Abstract] [Full Text] [Related]

  • 5. Vancomycin mass transfer characteristics of high-flux cellulosic dialysers.
    Scott MK, Mueller BA, Clark WR.
    Nephrol Dial Transplant; 1997 Dec; 12(12):2647-53. PubMed ID: 9430866
    [Abstract] [Full Text] [Related]

  • 6. Clearance of vancomycin during high-efficiency hemodialysis.
    Klansuwan N, Ratanajamit C, Kasiwong S, Wangsiripaisan A.
    J Med Assoc Thai; 2006 Jul; 89(7):986-91. PubMed ID: 16881431
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of vancomycin in patients undergoing hemodialysis with polyacrylonitrile.
    Torras J, Cao C, Rivas MC, Cano M, Fernandez E, Montoliu J.
    Clin Nephrol; 1991 Jul; 36(1):35-41. PubMed ID: 1889149
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A Pharmacokinetic Study Comparing the Clearance of Vancomycin during Haemodialysis Using Medium Cut-Off Membrane (Theranova) and High-Flux Membranes (Revaclear).
    Allawati H, Dallas L, Nair S, Palmer J, Thaikandy S, Hutchison C.
    Toxins (Basel); 2020 May 12; 12(5):. PubMed ID: 32408589
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cefazolin dialytic clearance by high-efficiency and high-flux hemodialyzers.
    Sowinski KM, Mueller BA, Grabe DW, Manley HJ, Frye RF, Bailie GR, Marx MA.
    Am J Kidney Dis; 2001 Apr 12; 37(4):766-76. PubMed ID: 11273877
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Removal of vancomycin by high-flux hemodialysis membranes.
    Quale JM, O'Halloran JJ, DeVincenzo N, Barth RH.
    Antimicrob Agents Chemother; 1992 Jul 12; 36(7):1424-6. PubMed ID: 1510437
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Adequacy of a vancomycin dosing regimen in patients receiving high-flux hemodialysis.
    Ariano RE, Fine A, Sitar DS, Rexrode S, Zelenitsky SA.
    Am J Kidney Dis; 2005 Oct 12; 46(4):681-7. PubMed ID: 16183423
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.